A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 178
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SDC
Long Form : Salivary duct carcinoma
No. Year Title Co-occurring Abbreviation
2019 Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma. ADT, AR, CI, DFS, LHRH, OS, R/M
2019 Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study. CAB, LA/RM, SGC
2019 Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naive salivary duct carcinomas. AR, AR-V7, IHC, ISH
2019 Metastatic salivary duct carcinoma in cardiac and pleural effusions: A case report with immunocytochemical analysis for androgen receptor and HER2. AR, HER
2019 Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma. ---
2019 Salivary Duct Carcinoma of the Parotid Gland Originating from an Epithelial-Myoepithelial Carcinoma: Report of a Rare Case. AR, EMC, GCDFP-15, HER2
2019 Synchronous salivary duct carcinoma and Warthin's tumour in the same parotid gland: Cytological features and differential diagnosis. PA, WT
2018 A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands. AR, DFS, DMFS, HER2, IHC, OS
10  2018 Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis. AR, ASCC, CXPA, GCDFP, PA, SCC
11  2018 Bone marrow metastases in salivary duct carcinoma of the parotid gland. ---
12  2018 Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma. DMFS, LRFFS, OS
13  2018 Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis. GalRs, HER2, OS
14  2018 Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. AR, ER, PR, SGTs
15  2018 Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma. AR, HMGA2, PA, PLAG1
16  2018 First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition. ---
17  2018 Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. HER2, p-Akt, PI3K, PIK3CA, PTEN
18  2018 HER2/HER3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report. CT
19  2018 Metastatic Salivary Ductal Carcinoma to the Mastoid Segment of the Facial Nerve. ---
20  2018 MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene. DCIS, miRNA
21  2018 PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. CA ex-PA, FISH, IHC, PA, PLAG1
22  2018 Radiotherapy as salvage treatment of salivary duct carcinoma in major salivary glands without radical operations. LRC
23  2018 Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland. IC
24  2018 Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study. AR, ERalpha, IDC, PR
25  2018 Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review. ---
26  2018 Salivary duct carcinoma. IDC
27  2018 Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute. AR, RT
28  2018 Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells. ---
29  2018 The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma. PD-L, TIMC
30  2018 The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases. AR, LI
31  2018 The implications of TrkA and MET aberrations in de novo salivary duct carcinoma. Trk
32  2018 The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. ---
33  2017 223Ra Dichloride Bone-Targeted Therapy in a Case of Metastatic Salivary Duct Carcinoma. AR, PCa
34  2017 Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification. ---
35  2017 Carcinoma ex basal cell adenoma of the parotid gland: A report of an extremely rare case. AR, BCA, GCDFP-15, MMG
36  2017 Denovo High Grade Salivary Duct Carcinoma: A Case Report and Review of Literature. ---
37  2017 Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan. CRP, mGPS, NLR, OS, PFS, PLR
38  2017 Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : Amonocentric clinicopathologic analysis. AR, DFS, DMFS, EGFR, ER, LRC, PD-L1-R, PR
39  2017 Salivary duct carcinoma arising from the inferior turbinate. ---
40  2017 Salivary Duct Carcinoma with Invasive Micropapillary and Rhabdoid Feature Arising in the Submandibular Gland. ---
41  2017 Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. ---
42  2017 Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy. ---
43  2017 Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry. AR
44  2017 Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report. LNMs
45  2016 Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells. AR, DHT
46  2016 Carcinoma ex pleomorphic adenoma of the parotid gland: a multi-institutional retrospective analysis in the Northern Japan Head and Neck Cancer Society. CXPA
47  2016 Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients. DFS, OS
48  2016 Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland. DM, LRRs, PORT
49  2016 Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer. ADT, AR
50  2016 Invasive micropapillary salivary duct carcinoma mixed with mucin-rich salivary duct carcinoma in minor salivary gland: a rare case report. ---
51  2016 MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas. ---
52  2016 Primary salivary duct carcinoma arising from the Stensen duct. ---
53  2016 Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations. Ca-ex-PA, CGP, GA
54  2016 Salivary duct carcinoma in the mandibular anterior region: The role of immunohistochemical markers in its definitive diagnosis. ---
55  2016 Salivary Duct Carcinoma of the Parotid: Outcomes with a Contemporary Multidisciplinary Treatment Approach. ---
56  2016 Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. ERBB2, FGFR1, FISH, HMGA2, PA, PLAG1, TP53
57  2015 Abiraterone in metastatic salivary duct carcinoma. ---
58  2015 Androgen receptor-positive mucoepidermoid carcinoma: case report and literature review. AR, MEC
59  2015 Breast metastasis of salivary duct carcinoma in a patient: a case report. ---
60  2015 Carcinoma ex-pleomorphic adenoma of the parotid gland consisting of high-grade salivary duct carcinoma and keratinizing squamous cell carcinoma. CXPA, FNA, SCC
61  2015 Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma. AR, DFS, EGFR, HER2, OS
62  2015 Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. SMG, TAM
63  2015 Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling. ---
64  2015 HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up. ---
65  2015 Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature. ---
66  2015 Immunohistochemical analysis of CD34 expression in salivary gland tumors. AdCC, MEC, MVD, PA
67  2015 Molecular characterization of apocrine salivary duct carcinoma. ---
68  2015 Prognostic factors and outcome analysis of salivary duct carcinoma. DFS, DMFS, OS, PNI
69  2015 Salivary duct carcinoma of the parotid gland: A case report and review of the literature. CK, HER-2
70  2015 Salivary duct carcinoma: A clinopathological report of 11 cases. ---
71  2015 Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. AR, HGT, IHC, SCC
72  2015 Sarcomatoid salivary duct carcinoma of the palate: a rare casereport. ---
73  2014 Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. AR
74  2014 Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland. ---
75  2014 Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy. ADT, PET
76  2014 High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma. CNVs
77  2014 Intramedullary spinal cord metastasis from salivary ductal carcinoma of the parotid gland mimicking transverse myelitis in a patient with radiologically isolated syndrome. ISCMs, MRI
78  2014 Intraoral salivary duct carcinoma: A case report and a brief review. CEA, ER, HMWCK, LMWCK
79  2014 Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma. GC, HER2, IDC, ITH
80  2014 Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma. ---
81  2014 Pleural fluid metastases of salivary duct carcinoma: A case report and review of the literature. ---
82  2014 Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience. DFFS, LRFFS, OS, PFS
83  2014 Primary ductal adenocarcinoma of the lacrimal gland, associated with abundant intracytoplasmic lumens containing some eosinophilic hyaline globules: cytological, histological and ultrastructural findings. IDC, PDA
84  2014 Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma. CI, OS, PA
85  2014 Salivary duct carcinoma in the mandible. ---
86  2014 Salivary duct carcinoma of the palatal salivary glands: a case report. ---
87  2014 Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required? HER2
88  2014 Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. DSS, OS, SEER
89  2013 An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. DCIS, FISH, HN, LGCCC, PA
90  2013 Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma. CXPA, HER2
91  2013 Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. ACC, CNAs, MEC
92  2013 Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. ---
93  2013 Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma. IHC, USP22
94  2013 Management and outcome of salivary duct carcinoma in major salivary glands. ---
95  2013 PIK3CA mutations and PTEN loss in salivary duct carcinomas. PI3K, PTEN
96  2013 Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors. CTV, DFS, LC, OS
97  2013 Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature. ---
98  2013 Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification. ---
99  2013 The role of trastuzumab in the management of salivary ductal carcinomas. HER2
100  2013 Trastuzumab for the treatment of salivary duct carcinoma. ---